Spectrum of gene mutations identified by targeted next‐generation sequencing in Chinese leukemia patients

Background Despite targeted sequencing have identified several mutations for leukemia, there is still a limit of mutation screening for Chinese leukemia. Here, we used targeted next‐generation sequencing for testing the mutation patterns of Chinese leukemia patients. Methods We performed targeted se...

Full description

Saved in:
Bibliographic Details
Published in:Molecular genetics & genomic medicine Vol. 8; no. 9; pp. e1369 - n/a
Main Authors: Yao, Hongxia, Wu, Congming, Chen, Yueqing, Guo, Li, Chen, Wenting, Pan, Yanping, Fu, Xiangjun, Wang, Guyun, Ding, Yipeng
Format: Journal Article
Language:English
Published: Bognor Regis John Wiley & Sons, Inc 01-09-2020
John Wiley and Sons Inc
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Despite targeted sequencing have identified several mutations for leukemia, there is still a limit of mutation screening for Chinese leukemia. Here, we used targeted next‐generation sequencing for testing the mutation patterns of Chinese leukemia patients. Methods We performed targeted sequencing of 504 tumor‐related genes in 109 leukemia samples to identify single‐nucleotide variants (SNVs) and insertions and deletions (INDELs). Pathogenic variants were assessed based on the American College of Medical Genetics and Genomics (ACMG) guidelines. The functional impact of pathogenic genes was explored through gene ontology (GO), pathway analysis, and protein–protein interaction network in silico. Results We identified a total of 4,655 SNVs and 614 INDELs in 419 genes, in which PDE4DIP, NOTCH2, FANCA, BCR, and ROS1 emerged as the highly mutated genes. Of note, we were the first to demonstrate an association of PDE4DIP mutation and leukemia. Based on ACMG guidelines, 39 pathogenic and likely pathogenic mutations in 27 genes were found. GO annotation showed that the biological process including gland development, leukocyte differentiation, respiratory system development, myeloid leukocyte differentiation, mesenchymal to epithelial transition, and so on were involved. Conclusion Our study provided a map of gene mutations in Chinese patients with leukemia and gave insights into the molecular pathogenesis of leukemia. We identified a total of 4,655 single‐nucleotide variants and 614 insertions and deletions in 419 genes, in which PDE4DIP, NOTCH2, FANCA, BCR and ROS1 emerged as the highly mutated genes. Based on American College of Medical Genetics and Genomics guidelines, 39 pathogenic and likely pathogenic mutations in 27 genes were found. Our study provided a map of gene mutations in Chinese patients with leukemia and gave insights into the molecular pathogenesis of leukemia.
Bibliography:Funding information
Hongxia Yao and Congming Wu were co‐first author.
This study was funded by National Natural Science Foundation of China (No. 81460031), Key Research and Development Program of Hainan Province (No. ZDYF2018116) and Application Research and Demonstration & Promotion of Hainan Province (No. ZDXM2014119).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2324-9269
2324-9269
DOI:10.1002/mgg3.1369